EcoDrugPlus

Integrin Subunit Beta 8

Ensembl ID : ENSECRG00000011851
Gene Symbol: ITGB8
3 Cross references
207 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSECRG00000000423
Gene Symbol: IRAK4
3 Cross references
202 Possible Orthologues:

Interleukin-8-Like

Ensembl ID : ENSECRG00000008748
Gene Symbol: LOC114655068
2 Cross references
175 Possible Orthologues:

Interleukin-8-Like

Ensembl ID : ENSECRG00000008730
Gene Symbol: LOC114654319
2 Cross references
175 Possible Orthologues:

Interleukin-8-Like

Ensembl ID : ENSECRG00000008739
Gene Symbol: LOC114654320
2 Cross references
175 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSECRG00000015540
Gene Symbol: IDH1
3 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSECRG00000018564
Gene Symbol: IDH2
3 Cross references
261 Possible Orthologues:

Isotocin Receptor-Like

Ensembl ID : ENSECRG00000016399
Gene Symbol: LOC114668793
3 Cross references
265 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSECRG00000019072
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSECRG00000011139
Gene Symbol: KDR
3 Cross references
199 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSECRG00000000974
Gene Symbol: KIF11
3 Cross references
202 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSECRG00000005368
Gene Symbol: KIF5B
3 Cross references
289 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).